223 related articles for article (PubMed ID: 16131979)
21. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
22. Nutritional management of cystic fibrosis patients.
Kalnins D; Durie PR; Pencharz P
Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):348-54. PubMed ID: 17414506
[TBL] [Abstract][Full Text] [Related]
23. Misdiagnosis of cystic fibrosis based on transient pancreatic insufficiency and elevated sweat chloride.
Bagheri-Behrouzi A; Steiß JO; Zimmer KP; Nährlich L
Klin Padiatr; 2015 Mar; 227(2):96-7. PubMed ID: 25751685
[No Abstract] [Full Text] [Related]
24. Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review).
Somaraju UR; Solis-Moya A
Paediatr Respir Rev; 2015 Mar; 16(2):108-9. PubMed ID: 25497671
[No Abstract] [Full Text] [Related]
25. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study.
Weintraub A; Blau H; Mussaffi H; Picard E; Bentur L; Kerem E; Stankiewicz H; Wilschanski M
J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):306-10. PubMed ID: 19274786
[TBL] [Abstract][Full Text] [Related]
26. [Digestive and nutritional management of adults with cystic fibrosis].
Marteau P; Munck A; Moreau J; Navarro J
Rev Mal Respir; 2000 Aug; 17(3 Pt 2):785-97. PubMed ID: 11076388
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
Trapnell BC; Maguiness K; Graff GR; Boyd D; Beckmann K; Caras S
J Cyst Fibros; 2009 Dec; 8(6):370-7. PubMed ID: 19815466
[TBL] [Abstract][Full Text] [Related]
28. Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice.
Wouthuyzen-Bakker M; Bodewes FA; Verkade HJ
J Cyst Fibros; 2011 May; 10(3):150-8. PubMed ID: 21459688
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis.
Baker SS; Borowitz D; Duffy L; Fitzpatrick L; Gyamfi J; Baker RD
J Pediatr; 2005 Feb; 146(2):189-93. PubMed ID: 15689904
[TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis. 6. Gastrointestinal and nutritional aspects.
Kopelman H
Thorax; 1991 Apr; 46(4):261-7. PubMed ID: 2038735
[No Abstract] [Full Text] [Related]
31. [Clinical and radiological findings in the gastrointestinal system in pancreatic insufficiency due to cystic fibrosis].
Pelizza A; Gargani GF; Romano C
Radiol Med; 1980 Sep; 66(9):626-9. PubMed ID: 7232794
[No Abstract] [Full Text] [Related]
32. Effect of an antioxidant-rich multivitamin supplement in cystic fibrosis.
Sagel SD; Sontag MK; Anthony MM; Emmett P; Papas KA
J Cyst Fibros; 2011 Jan; 10(1):31-6. PubMed ID: 20961818
[TBL] [Abstract][Full Text] [Related]
33. Fibrosing colonopathy in an adult caused by over use of pancreatic enzyme supplements.
Häusler M; Heimann G; Meilcke R; Biesterfeld S
Gut; 2000 Oct; 47(4):598. PubMed ID: 11203308
[No Abstract] [Full Text] [Related]
34. Infection of the respiratory tract and lungs in cystic fibrosis.
Williams RF
Nurs Times; 1980 Mar; 76(12):517-20. PubMed ID: 6899128
[No Abstract] [Full Text] [Related]
35. Effect of Oral Lipid Matrix Supplement on Fat Absorption in Cystic Fibrosis: A Randomized Placebo-Controlled Trial.
Stallings VA; Schall JI; Maqbool A; Mascarenhas MR; Alshaikh BN; Dougherty KA; Hommel K; Ryan J; Elci OU; Shaw WA
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):676-680. PubMed ID: 27050056
[TBL] [Abstract][Full Text] [Related]
36. The mechanisms of fat malabsorption in cystic fibrosis patients.
Kalivianakis M; Verkade HJ
Nutrition; 1999 Feb; 15(2):167-9. PubMed ID: 9990588
[No Abstract] [Full Text] [Related]
37. Pancreatic insufficiency in cystic fibrosis.
Rothman S
Gastroenterology; 1996 Sep; 111(3):833. PubMed ID: 8780596
[No Abstract] [Full Text] [Related]
38. Novel approaches to inflammation and infection in the cystic fibrosis lung.
Cantin AM
Pediatr Pulmonol; 2001; Suppl 23():94-6. PubMed ID: 11886164
[No Abstract] [Full Text] [Related]
39. [Cystic fibrosis; current therapy. Infections].
Schaad UB
Schweiz Med Wochenschr Suppl; 2000; 122():22S-23S. PubMed ID: 12536466
[No Abstract] [Full Text] [Related]
40. [Pathomorphosis of cystic fibrosis. Current medical and surgical problems in the improved prognosis of cystic fibrosis].
Romano C
Minerva Pediatr; 1981 Jul; 33(14):677-702. PubMed ID: 7027012
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
